anti-Scl-70
Selected indexed studies
- Anti-scl-70. (Autoimmunity, 2005) [PMID:15804707]
- Anti-Scl-70 (topo-I) antibodies in SLE: Myth or reality? (Autoimmun Rev, 2010) [PMID:20601198]
- False positive anti-Topoisomerase I (Scl-70) antibody results in clinical practice: A case series from a scleroderma referral center. (Semin Arthritis Rheum, 2022) [PMID:35753143]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Systemic Sclerosis (Scleroderma). (2026) pubmed
- Anti-scl-70. (2005) pubmed
- Anti-Scl-70 (topo-I) antibodies in SLE: Myth or reality? (2010) pubmed
- False positive anti-Topoisomerase I (Scl-70) antibody results in clinical practice: A case series from a scleroderma referral center. (2022) pubmed
- Interstitial lung disease associated with systemic sclerosis (SSc-ILD). (2019) pubmed
- [Anti-Scl-70 antibody (anti-topoisomerase I antibody)]. (1999) pubmed
- Test performance in systemic sclerosis: anti-centromere and anti-Scl-70 antibodies. (1997) pubmed
- Moyamoya vasculopathy with anti-SCL-70 antibodies: A case report and review of the literature. (2018) pubmed
- The Effect of Anti-Scl-70 Antibody Determination Method on Its Predictive Significance for Interstitial Lung Disease Progression in Systemic Sclerosis. (2022) pubmed
- Problem of low specificity for anti-Scl-70 antibody assay in commercial laboratories. (2022) pubmed